Investigating the nutritional status characteristics of terminal cancer patients by the type of cancer

按癌症类型调查晚期癌症患者的营养状况特征

阅读:3

Abstract

OBJECTIVE: Patients with terminal cancer experience malnutrition due to cachexia and other problems associated with the disease's progression. Particularly, patients with gastrointestinal cancers often experience malnutrition because of gastrointestinal symptoms; however, there are few reports evaluating nutritional status based on cancer type up to the prediction of prognosis. In the present study, we examined nutritional evaluation and prognosis based on cancer type. METHODS: In 2019, 234 patients were admitted to Fujita Health University Nanakuri Memorial Hospital and subsequently died before being discharged. Of these patients, 210 were included in the study. Twenty-four patients who were determined to have refractory cachexia on admission were excluded. The 210 patients were divided into two groups, 94 and 116 patients with gastrointestinal cancers and non-gastrointestinal cancers, respectively. Subsequently, data, such as age, sex, presence or absence of metastasis, whether the cancer was initial or recurrent, serum albumin (Alb) and transthyretin (TTR) levels on admission, and survival time were examined. Moreover, for further analysis, the 94 patients with gastrointestinal cancers were classified into 51 and 43 with hepato-biliary-pancreas cancer and gastrointestinal tract cancers, respectively. RESULTS: Alb and TTR values were significantly lower in patients with gastrointestinal cancer than in patients with non-gastrointestinal cancer (p=0.015 and 0.002, respectively), and Alb values were significantly lower in patients with gastrointestinal tract cancer than in patients with hepato-biliary-pancreas cancer (p=0.049). CONCLUSION: Patients with terminal cancer having poor nutritional status exhibit poor prognosis. Particularly, among patients with gastrointestinal tract cancer have exceptionally poor nutritional status. Therefore, providing nutritional management that combines intravenous nutrition with appropriate adjustments to each patient's gastrointestinal and absorptive condition is important.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。